Kieran Deane-Alder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kieran Deane-Alder has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Affiong I. Oqua
Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
1 shared publication - Alejandra Tomas
Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
1 shared publication - Alex Montoya
Biological Mass Spectrometry and Proteomics Facility, MRC Laboratory of Medical Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK
1 shared publication - André Mateus
Umeå University
1 shared publication - Ben Jones
Section of Endocrinology Imperial College London London UK
1 shared publication - Christopher Arthur Reynolds
Coventry University
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (6) , eadw0899
In vivo functional profiling and structural characterization of the human GLP1R A316T variant
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective therapies for type 2 diabetes (T2D) and obesity, yet patient responses are variable, with GLP1R gene variation potentially linked to therapeutic outcomes. A GLP1R natural missense variant, A316T, protects against T2D and cardiovascular disease. Here, we generated and characterized a human GLP1R A316T mouse model. Human GLP1R A316T/A316T mice displayed lower fasting blood glucose versus wild-type littermates even under metabolic stress, as well as slower weight gain and alterations in islet cytoarchitecture, glucagon secretion, and liver metabolism under a high-fat, high-sucrose diet. This was however associated with blunted responses to pharmacological GLP-1RAs in vivo. Further investigations in β cell models demonstrated that human GLP1R A316T exhibits characteristics of constitutive activation but dampened GLP-1RA responses. Results are further supported by cryo-EM analyses and molecular dynamics simulations of GLP-1R A316T structure, collectively demonstrating that the A316T variant governs basal GLP-1R activity and pharmacological responses to GLP-1R–targeting therapies.
- 6 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (6) , eadw0899
Open AccessIn vivo functional profiling and structural characterization of the human GLP1R A316T variant
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective therapies for type 2 diabetes (T2D) and obesity, yet patient responses are variable, with GLP1R gene variation potentially linked to therapeutic outcomes. A GLP1R natural missense variant, A316T, protects against T2D and cardiovascular disease. Here, we generated and characterized a human GLP1R A316T mouse model. Human GLP1R A316T/A316T mice displayed lower fasting blood glucose versus wild-type littermates even under metabolic stress, as well as slower weight gain and alterations in islet cytoarchitecture, glucagon secretion, and liver metabolism under a high-fat, high-sucrose diet. This was however associated with blunted responses to pharmacological GLP-1RAs in vivo. Further investigations in β cell models demonstrated that human GLP1R A316T exhibits characteristics of constitutive activation but dampened GLP-1RA responses. Results are further supported by cryo-EM analyses and molecular dynamics simulations of GLP-1R A316T structure, collectively demonstrating that the A316T variant governs basal GLP-1R activity and pharmacological responses to GLP-1R–targeting therapies.
- Open Access
Pili-like proteins are essential for conjugation also in Gram-positive bacteria
Type IV secretion systems (T4SS) enable the spread of antibiotic resistance and other virulence factors. In Gram-positive bacteria, T4SSs have long been thought to lack VirB2-like proteins that form conjugative pili and instead rely on adhesins for cell-cell contacts. Yet, it has remained unclear how subsequent DNA transfer (conjugation) is mediated. Here we identify a VirB2-like protein, PrgFB2, from the clinically isolated plasmid pCF10 in Enterococcus faecalis and show that it is essential for conjugation. Structural modelling confidently predicts a pilus-like assembly for PrgFB2. This is in line with recently proposed models for conjugative pili in Gram-negative T4SSs. We validate the PrgFB2 pili prediction through mutagenesis, conjugation assays, and targeted chemical labelling. By combining various machine learning bioinformatic techniques, we analysed >1000 Gram-positive conjugative plasmids from diverse species, including major pathogens, and identified probable pili-forming VirB2-like proteins in a large majority. Our findings challenge the prevailing view that Gram-positive T4SSs lack pili and highlight critical targets for combating antimicrobial resistance and virulence in Gram-positive bacteria.
Open AccessPili-like proteins are essential for conjugation also in Gram-positive bacteria
Type IV secretion systems (T4SS) enable the spread of antibiotic resistance and other virulence factors. In Gram-positive bacteria, T4SSs have long been thought to lack VirB2-like proteins that form conjugative pili and instead rely on adhesins for cell-cell contacts. Yet, it has remained unclear how subsequent DNA transfer (conjugation) is mediated. Here we identify a VirB2-like protein, PrgFB2, from the clinically isolated plasmid pCF10 in Enterococcus faecalis and show that it is essential for conjugation. Structural modelling confidently predicts a pilus-like assembly for PrgFB2. This is in line with recently proposed models for conjugative pili in Gram-negative T4SSs. We validate the PrgFB2 pili prediction through mutagenesis, conjugation assays, and targeted chemical labelling. By combining various machine learning bioinformatic techniques, we analysed >1000 Gram-positive conjugative plasmids from diverse species, including major pathogens, and identified probable pili-forming VirB2-like proteins in a large majority. Our findings challenge the prevailing view that Gram-positive T4SSs lack pili and highlight critical targets for combating antimicrobial resistance and virulence in Gram-positive bacteria.